The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components: T The extent of the primary tumour N The absence or presence and extent of regional lymph node metastasis M The absence or presence of distant metastasis. TNM classification for the above site is described under the following headings: Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment Anatomical sites and subsites where appropriate Definition of the regional lymph nodes TNM Clinical classification pTNM Pathological classification G Histopathological grading Stage grouping Summary
The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components: T The extent of the primary tumour N The absence or presence and extent of regional lymph node metastasis M The absence or presence of distant metastasis. TNM classification for the above site is described under the following headings: Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment Anatomical sites and subsites where appropriate Definition of the regional lymph nodes TNM Clinical classification pTNM Pathological classification G Histopathological grading Stage grouping Summary
The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components: T The extent of the primary tumour N The absence or presence and extent of regional lymph node metastasis M The absence or presence of distant metastasis. TNM classification for the above site is described under the following headings: Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment Anatomical sites and subsites where appropriate Definition of the regional lymph nodes TNM Clinical classification pTNM Pathological classification G Histopathological grading Stage grouping Summary
The site is described under the following headings: Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment Anatomical subsites Definition of the regional lymph nodes TNM Clinical classification pTNM Pathological classification G Histopathological grading R Classification Stage grouping Summary
The following sites are included: Vulva Vagina Cervix uteri Corpus uteri Ovary Fallopian tube Gestational trophoblastic tumours Cervix uteri and corpus uteri were among the first sites to be classified by the TNM system. The “League of Nations” stages for carcinoma of the cervix have been used with minor modifications for over 50 years, and, because these are accepted by the Fédération Internationale de Gynécologie et d'Obstétrique (FIGO), the TNM categories have been defined to correspond to the FIGO stages. Some amendments have been made in collaboration with FIGO, and the classifications now published have the approval of the FIGO, UICC, and the national TNM committees including the AJCC. Each site is described under the following headings: Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment Anatomical subsites where appropriate Definition of the regional lymph nodes TNM Clinical classification pTNM Pathological classification Stage grouping Summary
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.